{"id":"https://openalex.org/W7099158441","doi":null,"title":"Reduction of disulfide bonds within anti-D results in enhanced Fcg receptor blockade","display_name":"Reduction of disulfide bonds within anti-D results in enhanced Fcg receptor blockade","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7099158441"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.621.5504","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.621.5504","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodservices.ca/CentreApps/Internet/UW_V502_MainEngine.nsf/resources/Medical_Publications/$file/Reduction_of_disulfide_bonds_within_anti-D_results.pdf","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7099158441"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5043182293","display_name":"Andrew S. Kruspe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Andrew S. Kruspe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062657054","display_name":"Yulia Katsman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Yulia Katsman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065233057","display_name":"Darinka Sakac","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Darinka Sakac","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074813175","display_name":"C\u00e9cile Chagneau","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C\u00e9cile Chagneau","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025303996","display_name":"Anna Glistvain","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anna Glistvain","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019614474","display_name":"Richard Francis Langler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Richard F. Langler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5040888166","display_name":"Donald R. Branch","orcid":"https://orcid.org/0000-0002-8974-2451","observed_orcids":["https://orcid.org/0000-0002-8974-2451"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Donald R. Branch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.9185000061988831,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11660","display_name":"Blood groups and transfusion","score":0.06509999930858612,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10308","display_name":"Systemic Lupus Erythematosus Research","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-d","display_name":"anti-D","score":0.6430000066757202},{"id":"https://openalex.org/keywords/disulfide-reduction","display_name":"disulfide bond reduction","score":0.8579999804496765},{"id":"https://openalex.org/keywords/dithiothreitol","display_name":"dithiothreitol","score":0.7570000290870667},{"id":"https://openalex.org/keywords/iodoacetamide","display_name":"iodoacetamide","score":0.9919999837875366},{"id":"https://openalex.org/keywords/sulfhydryl-reagents","display_name":"sulfhydryl reagents","score":0.5370000004768372},{"id":"https://openalex.org/keywords/antibody-structure","display_name":"antibody structure","score":0.6470000147819519},{"id":"https://openalex.org/keywords/immune-cytopenias","display_name":"immune cytopenias","score":0.8640000224113464},{"id":"https://openalex.org/keywords/monocyte-monolayer-assay","display_name":"monocyte monolayer assay","score":0.8989999890327454}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7193999886512756},{"id":"https://openalex.org/C27256138","wikidata":"https://www.wikidata.org/wiki/Q1230226","display_name":"Disulfide bond","level":2,"score":0.6219000220298767},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.6215000152587891},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5963000059127808},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5522000193595886},{"id":"https://openalex.org/C160448771","wikidata":"https://www.wikidata.org/wiki/Q184726","display_name":"Phagocytosis","level":2,"score":0.5321999788284302},{"id":"https://openalex.org/C89372155","wikidata":"https://www.wikidata.org/wiki/Q420107","display_name":"Opsonin","level":3,"score":0.48399999737739563},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4659999907016754},{"id":"https://openalex.org/C2780898057","wikidata":"https://www.wikidata.org/wiki/Q79448","display_name":"Immunoglobulin G","level":3,"score":0.40950000286102295},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4023999869823456},{"id":"https://openalex.org/C2778474638","wikidata":"https://www.wikidata.org/wiki/Q575241","display_name":"Immune complex","level":3,"score":0.3882000148296356},{"id":"https://openalex.org/C2781184567","wikidata":"https://www.wikidata.org/wiki/Q107244","display_name":"Monocyte","level":2,"score":0.37540000677108765},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.37529999017715454},{"id":"https://openalex.org/C2777210771","wikidata":"https://www.wikidata.org/wiki/Q4927124","display_name":"Block (permutation group theory)","level":2,"score":0.367000013589859},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.3653999865055084},{"id":"https://openalex.org/C2779931124","wikidata":"https://www.wikidata.org/wiki/Q417823","display_name":"Fc receptor","level":3,"score":0.3621000051498413},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3450999855995178},{"id":"https://openalex.org/C111335779","wikidata":"https://www.wikidata.org/wiki/Q3454686","display_name":"Reduction (mathematics)","level":2,"score":0.3294999897480011},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3199999928474426},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.31949999928474426},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.31700000166893005},{"id":"https://openalex.org/C125823703","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Fragment crystallizable region","level":3,"score":0.29760000109672546},{"id":"https://openalex.org/C7070889","wikidata":"https://www.wikidata.org/wiki/Q902488","display_name":"Monolayer","level":2,"score":0.2953999936580658},{"id":"https://openalex.org/C2909900342","wikidata":"https://www.wikidata.org/wiki/Q1616930","display_name":"Immunoglobulin Fc Fragments","level":4,"score":0.29280000925064087},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.27639999985694885},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2702000141143799},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2660999894142151},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2531999945640564},{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.25049999356269836}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.621.5504","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.621.5504","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.bloodservices.ca/CentreApps/Internet/UW_V502_MainEngine.nsf/resources/Medical_Publications/$file/Reduction_of_disulfide_bonds_within_anti-D_results.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2070810486","https://openalex.org/W2101465046","https://openalex.org/W2077218639","https://openalex.org/W2060346867","https://openalex.org/W2293056973","https://openalex.org/W4312573480","https://openalex.org/W3003191003","https://openalex.org/W2051904646","https://openalex.org/W2105605048","https://openalex.org/W4230855508"],"abstract_inverted_index":{"cals":[0],"known":[1],"to":[2,23,36,61,101],"disrupt":[3],"disulfide":[4],"bonds":[5],"are":[6],"capable":[7],"of":[8,18,40,65,69],"altering":[9],"immunoglobulin":[10,48],"anti-D":[11,22],"structure":[12],"resulting":[13],"in":[14,47],"an":[15],"increased":[16],"efficacy":[17],"the":[19,66],"chemically":[20],"modified":[21],"inhibit":[24],"Fcg":[25],"receptor":[26],"(FcgR)-mediated":[27],"phagocytosis.":[28],"If":[29],"successful,":[30],"this":[31,38],"would":[32],"provide":[33],"a":[34,76],"rationale":[35],"explore":[37],"mechanism":[39],"enhancing":[41],"FcgR":[42],"blockade":[43],"for":[44,50],"future":[45],"use":[46],"therapies":[49],"immune":[51],"cytopenias.":[52],"STUDY":[53],"DESIGN":[54],"AND":[55],"METHODS:":[56],"Anti-D":[57],"that":[58],"was":[59,81,105],"shown":[60],"block":[62],"50":[63],"percent":[64],"FcgR-mediated":[67],"phagocytosis":[68],"opsonized":[70],"red":[71],"blood":[72],"cells":[73],"(RBCs)":[74],"using":[75],"monocyte":[77],"monolayer":[78],"assay":[79],"(MMA)":[80],"combined":[82],"with":[83,93,97],"two":[84],"different":[85],"thiol-containing":[86],"compounds,":[87],"dithio-threitol":[88],"(DTT)":[89],"or":[90,94],"p-toluenesulfonylmethyl":[91],"mercaptan,":[92],"without":[95],"treatment":[96],"iodoacetamide,":[98],"and":[99],"allowed":[100],"react.":[102],"Excess":[103],"chemical":[104],"removed":[106],"by":[107]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7099158441","counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2025-10-27T00:00:00"}
